Colorectal Cancer Therapy | Middlesex University London
Saved pages
0

    Close window

    Section navigation

    Colorectal Cancer Therapy

    Colorectal cancer therapy

    Background

    Colorectal cancer is one of the most common forms of cancer. While the primary tumour can be surgically removed or ablated by radiotherapy, neither procedure is able to eliminate secondary metastatic growths at distant sites. Therapy with cytotoxic drugs (chemotherapy) can hunt down these metastases but there are most unpleasant side-effects due to the drugs attacking non-tumour sites. 

    The project

    We aim to deliver cytotoxic drugs to the tumours selectively by attaching the drugs to minute gold particles, or 'nanoparticles' (5 million = 1 cm). The nanoparticles will targeted specifically at the surface of the cancer cell and the drug released intracellularly, exactly in the location for it to be effective (see cancer targetting illustration above).

    This will have the double advantage of being highly successful at killing the cancer cells while causing minimal side-effects, as the non-tumour sites are left alone.

    Project team

    Professor I M Roitt – Lead

    Dr T Lund – Cellular targeting of gold nanoparticles

    Midatech Ltd  – Tuning gold nanoparticles

    In this section

    Back to top

    We use Cookies

    View our Privacy and Cookie policy

    Continue